Bharat Biotech

Union Health Minister launches first made-in-India intranasal Covid vaccine 

The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.

published on : 26th January 2023

India's first intranasal Covid vaccine to be launched on Jan 26

In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.

published on : 21st January 2023

Germany to recognise Covaxin for travel purpose from June 1, says envoy

In November last year, the World Health Organisation recommended Emergency Use Listing (EUL) status for Covaxin.

published on : 26th May 2022

Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech

WHO chief scientist Soumya Swaminathan had said that the global health body is likely to take a decision on Covaxin in the emergency use listing within four to six weeks.

published on : 12th July 2021

If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

published on : 24th August 2020